Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1103
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01193608 | Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease | ||
| NCT02877225 | Study to Assess the Bioequivalence of Ibrutinib 140 Milligram (mg) Tablet to 140 mg IMBRUVICA Capsule | ||
| NCT04023526 | A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy | ||
| NCT02421185 | Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular Carcinoma | ||
| NCT04936308 | Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent | ||
| NCT03207724 | Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia | ||
| NCT02065791 | Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy | ||
| NCT06741969 | Nipocalimab in Moderate to Severe Sjogren's Disease | ||
| NCT04235270 | A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants | ||
| NCT05963074 | A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia | ||
| NCT02564718 | Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates | ||
| NCT05275023 | An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants | ||
| NCT05453903 | A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies | ||
| NCT06425991 | A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT06768489 | A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma | ||
| NCT06878404 | A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis | ||
| NCT01858519 | Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy | ||
| NCT06028438 | A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis | ||
| NCT01978548 | A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease | ||
| NCT01677598 | A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries | ||
| NCT05007756 | A Study Exploring the Use of Challenge Agents in Healthy Volunteers or Participants With a Disease of Interest | ||
| NCT02438787 | A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis | ||
| NCT04116164 | Safety and Targeting of Anti-hk2 Antibody in mCRPC | ||
| NCT04948398 | Post-Trial Access for Guselkumab in Participants With Familial Adenomatous Polyposis | ||
| NCT05441501 | A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer | ||
| NCT01788436 | A Study to Assess Learning Performance in Patients With Schizophrenia and Young and Elderly Healthy Volunteers | ||
| NCT07308132 | A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies | ||
| NCT07276399 | A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer | ||
| NCT00575055 | Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) | ||
| NCT01925755 | Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients | ||
| NCT02221726 | Study to Assess Adhesion Quality and Wear of Placebo JNJ-35685-AAA-G-023 Transdermal System in Healthy Adults | ||
| NCT06120140 | Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib | ||
| NCT01947959 | Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany) | ||
| NCT01369355 | A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) | ||
| NCT00021723 | Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease | ||
| NCT02230059 | Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC) | ||
| NCT04181827 | A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma | ||
| NCT04511611 | Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 10 mg in Japanese Healthy Male Adult Subjects | ||
| NCT04844463 | A Study of JNJ-68179280 in Healthy Participants | ||
| NCT02336698 | Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002 | ||
| NCT03474757 | Treatment Pattern of NOACs (Non-vitamin K Oral Anticoagulants) in Outpatient Users in Colombian Databases | ||
| NCT01137812 | The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial) | ||
| NCT05221619 | Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA) | ||
| NCT02260700 | A Study to Evaluate Bioavailability, Food Effect, Safety and Tolerability of a Solid Dosage Formulation of JNJ-54861911 in Healthy Older Male Participants | ||
| NCT02854436 | An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies | ||
| NCT07220824 | A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting | ||
| NCT02691520 | Epidemiology of Treatment Resistant Depression in Taiwan | ||
| NCT01480388 | A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate | ||
| NCT01369342 | A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2) | ||
| NCT01909427 | An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
